Ascentage Pharma Group International (AAPG)
NASDAQ: AAPG · Real-Time Price · USD
32.88
+2.18 (7.10%)
At close: Dec 5, 2025, 4:00 PM EST
34.32
+1.44 (4.38%)
After-hours: Dec 5, 2025, 7:49 PM EST
AAPG Employees
Ascentage Pharma Group International had 567 employees as of December 31, 2024. The number of employees decreased by 16 or -2.74% compared to the previous year.
Employees
567
Change (1Y)
-16
Growth (1Y)
-2.74%
Revenue / Employee
$96,163
Profits / Employee
-$285,386
Market Cap
3.00B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
AAPG News
- 1 day ago - Ascentage Pharma Announces Global Registrational Phase III Study of Olverembatinib in First-Line Treatment of Ph+ ALL Cleared by US FDA and EMA - GlobeNewsWire
- 11 days ago - Ascentage Pharma Announces Publication of Olverembatinib Phase Ib Safety, Efficacy and Novel Mechanism Data in Gastrointestinal Stromal Tumors in Nature's Signal Transduction and Targeted Therapy - GlobeNewsWire
- 17 days ago - Ascentage Pharma to Participate in Three Upcoming Investor Conferences in December 2025 - GlobeNewsWire
- 4 weeks ago - Ascentage Pharma to Present Data from Multiple Studies of Olverembatinib, Including the First Dataset from POLARIS-1 Study, at ASH 2025 - GlobeNewsWire
- 4 weeks ago - Ascentage Pharma to Present Data from Two Clinical Studies for Bcl-2 Inhibitor Lisaftoclax, Including an Oral Report, at ASH 2025 - GlobeNewsWire
- 5 weeks ago - Ascentage Pharma to Participate in Two Upcoming Investor Conferences in November 2025 - GlobeNewsWire
- 3 months ago - Ascentage Pharma Group International (AAPG) Presents At Citi's Biopharma Back To School Conference Transcript - Seeking Alpha
- 3 months ago - Ascentage Pharma Reports 2025 Interim Unaudited Six Months Financial Results and Business Updates - GlobeNewsWire